Management update

RNS Number : 3526B
Spire Healthcare Group PLC
11 February 2022
 

Spire Healthcare Group plc

 

("Spire Healthcare", "the Company" or "the Group")

 

Management update

 

11 February 2022

 

We are sorry to announce that Jitesh Sodha, Chief Financial Officer, recently suffered an injury whilst cycling. He was in a serious condition but is now recovering well in hospital.

 

Harbant Samra, Group Financial Controller, is taking on Jitesh's responsibilities in his absence, reporting to Justin Ash, Chief Executive Officer. Harbant is a Chartered Accountant and has been at Spire Healthcare for three years.

 

Justin Ash commented: "We are very pleased and relieved that Jitesh is recovering well. We send our very best wishes to him and his family. Jitesh may be absent for some time, but we anticipate he will fully resume his responsibilities in due course. Our management team and senior leadership will continue to discharge Jitesh's responsibilities in his absence."

 

Spire Healthcare confirms that, as previously announced, it will release its preliminary results for the year ended 31 December 2021 on 3 March 2022.

 

- Ends -

 

For further information please contact:

 

Spire Healthcare

Angus Prentice - Interim Head of Investor Relations  +44 (0)7974 982 512

 

Instinctif Partners

Damian Reece                                                                   +44 (0)7931 598 593

Guy Scarborough                                                               +44 (0)7917 178 920

Jeremy Durrant                                                                  +44 (0)7792 918 648

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics across England, Wales and Scotland.

 

Working in partnership with around 7,500 experienced consultants, Spire Healthcare delivered tailored, personalised care to almost 750,000 in-patients and daycase patients in 2020, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

 

The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 95% of Spire Healthcare's hospitals are rated 'Good' or 'Outstanding' by the CQC (or the equivalent in Scotland and Wales).

 

Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUBAPUPPGQU
UK 100

Latest directors dealings